Sivelestat attenuates postoperative pulmonary dysfunction after total arch replacement under deep hypothermia

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 4, 2008, Pages 798-804

  Morimoto, Naoto ^a   Morimoto, Keisuke ^a   Morimoto, Yoshihisa ^a   Takahashi, Hiroaki ^a   Asano, Mitsuru ^a   Matsumori, Masamichi ^a   Okada, Kenji ^a   Okita, Yutaka ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiopulmonary bypass; Postperfusion pulmonary dysfunction; Total arch replacement

Indexed keywords

APROTININ; FENTANYL; MIDAZOLAM; PROPOFOL; SIVELESTAT; VECURONIUM;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AORTIC ARCH SURGERY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMODYNAMICS; HUMAN; HYPOTHERMIA; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPERATION DURATION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; SIDE EFFECT; TRACHEOSTOMY; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AORTA, THORACIC; AORTIC ANEURYSM; BLOOD VESSEL PROSTHESIS IMPLANTATION; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; FEMALE; GLYCINE; HEMODYNAMICS; HUMANS; HYPOTHERMIA, INDUCED; LUNG DISEASES; MALE; MIDDLE AGED; OXYGEN; OXYGEN CONSUMPTION; PARTIAL PRESSURE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 52949145249     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.07.010     Document Type: Article

References (19)

1. Pennock J.L., Pierce W.S., and Waldhausen J.A. The management of the lungs during cardiopulmonary bypass. Surg Gynecol Obstet 145 (1977) 917-927
2. Turnbull K.W., Miyagishima R.T., and Gerein A.N. Pulmonary complications and cardiopulmonary bypass: a clinical study in adults. Can Anesth Soc J 21 (1974) 181
3. Ng C.S.H., Wan S., Yim A.P.C., and Arifi A.A. Pulmonary dysfunction after cardiac surgery. Chest 121 (2002) 1269-1277
4. Yamazaki T., Ooshima H., Usui A., Watanabe T., and Yasuura K. Protective effects of ONO-5046-Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann Thorac Surg 68 (1999) 2141-2146
5. Kawabata K., Suzuki M., Sugitani M., Imaki K., Tada M., and Miyamoto T. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 177 (1991) 814-820
6. Kawabata K., Moore A.R., and Willoughby D.A. Impaired activity of protease inhibitor towards neutrophil elastase bound to human artificial cartilage. Ann Rheum Dis 55 (1996) 248-252
7. Sakamaki F., Ishizaka A., Urano T., Sayama K., Nakamura H., Terashima T., Waki Y., Tasaka S., Hasegawa N., Sato K., Nakagawa N., Obata T., and Kanazawa M. Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med 153 (1996) 391-397
8. Weiland J.E., Davis W.B., Holter J.F., Dorinsky P.M., and Gadek J.E. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathologic significance. Am Rev Respir Dis 133 (1986) 218-225
9. Suzuki N., Ishii Y., and Kitamura S. Mechanism for the increased permeability in endothelial monolayers induced by elastase. Mediators Inflamm 3 (1994) 11-16
10. Kawamura T., Wakusawa R., Okada K., and Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 40 (1993) 1016-1021
11. Ito H., Hamano K., Gohra H., Katoh T., Fujimura Y., Tsuboi H., and Esato K. Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today 27 (1997) 220-225
12. Matsuzaki K., Hiramatsu Y., Homma S., Sato S., Shigeta O., and Sakakibara Y. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg 80 (2005) 611-617
13. Nakajima M., and Kanemaru M. A phase I clinical study of a neutrophil elastase inhibitor; ONO-5046 Na in healthy volunteers. J Clin Therap Med 14 (1998) 195-218
14. Loser S.A., Scheeren T.W., and Tarnow J. How much oxygen dose the human lung consume?. Anesthesiology 86 (1997) 532-537
15. de Perrot M., Liu M., Waddel T.K., and Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 (2003) 490-511
16. Suzuki S., Sugawara T., Tabata T., Osihi H., Niikawa H., and Kondo T. Sivelestat reduces reperfusion injury of lungs harvested from endotoxin-primed rats by inhibition of neutrophil-mediated inflammation. J Heart Lung Transplant 26 (2007) 370-375
17. ishikawa N., Oda M., Kwaguchi M., Tsunezuka Y., and Watanabe G. The effects of a specific neutrophil elastase inhibitor (ONO-5046) in pulmonary ischemia-reperfusion injury. Transplant Int 16 (2003) 341-346
18. Geha A.S., Sessler A.D., and Kirklin J.W. Alveolar-arterial oxygen gradients after open intracardiac surgery. J Thorac Cardiovasc Surg 51 (1966) 609-615
19. Tamakuma S., Shiba T., Hirasawa H., Ogawa M., and Nakajima M. A phase III clinical study of a neutrophil elastase inhibitor. ONO-5046-Na in SIRS patients. J Clin Therap Med 14 (1998) 289-318